Rod phototransduction determines the trade-off of temporal integration and speed of vision in dark-adapted toads.

Human vision is approximately 10 times less sensitive than toad vision on a cool night. Here, we investigate (1) how far differences in the capacity for temporal integration underlie such differences in sensitivity and (2) whether the response kinetics of the rod photoreceptors can explain temporal integration at the behavioral level. The toad was studied as a model that allows experimentation at different body temperatures. Sensitivity, integration time, and temporal accuracy of vision were measured psychophysically by recording snapping at worm dummies moving at different velocities. Rod photoresponses were studied by ERG recording across the isolated retina. In both types of experiments, the general timescale of vision was varied by using two temperatures, 15 and 25 degrees C. Behavioral integration times were 4.3 s at 15 degrees C and 0.9 s at 25 degrees C, and rod integration times were 4.2-4.3 s at 15 degrees C and 1.0-1.3 s at 25 degrees C. Maximal behavioral sensitivity was fivefold lower at 25 degrees C than at 15 degrees C, which can be accounted for by inability of the "warm" toads to integrate light over longer times than the rods. However, the long integration time at 15 degrees C, allowing high sensitivity, degraded the accuracy of snapping toward quickly moving worms. We conclude that temporal integration explains a considerable part of all variation in absolute visual sensitivity. The strong correlation between rods and behavior suggests that the integration time of dark-adapted vision is set by rod phototransduction at the input to the visual system. This implies that there is an inexorable trade-off between temporal integration and resolution.

A new method for measuring free drug concentration: retinal tissue as a biosensor.

PURPOSE: To develop a method of using isolated rat retina as a biosensor in experiments on controlled drug release for measuring the resultant concentration of free model drug in living tissue and for testing the biocompatibility of the polymers and polymeric nanostructures used as drug carriers. METHODS: The method is based on the monotonic dependence of the photoresponse kinetics of retinal rods on the concentration of the membrane-permeable phosphodiesterase inhibitor 3-isobutyl-1-methylxanthine (IBMX). Changes in the time to peak (tp) of linear-range rod photoresponses were followed by transretinal ERG mass potential recordings in the aspartate-treated, dark-adapted rat retina. The dependence of tp on [IBMX] was measured, and the calibration curve thus obtained was used to determine the amount of IBMX released from polymeric structures. The biocompatibility of the carrier was first assessed by the degree to which rods retained stable function in the presence of the polymer or monomers alone. RESULTS: The dependence of tp on [IBMX] was well-described by a second-order polynomial. After each change of [IBMX], a new equilibrium state was reached within 6 to 9 minutes, depending on temperature. The amounts of IBMX released from biocompatible polymeric structures were measurable with good accuracy in the range 10 to 300 microM. CONCLUSIONS: This method enables accurate concentration determinations of the model drug IBMX in retinal tissue in drug-release experiments. The concentration dependence of the photoresponse kinetics has to be calibrated for each retina and temperature. The same preparation can be used for rapid testing of possible bioincompatibility of various molecules.